Sort by
Refine Your Search
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with
-
to strengths-based research that advances health equity for youth of color and their families using community engaged practices. The CHANGE lab, which is housed in the IHESJR, has areas of focus ranging across
-
, and scholarly activities. In partnership with Northeastern University, Dompe is offering a two-year Global Regulatory Affairs fellowship, based Remote with the option to relocate to San Mateo, CA
-
Affairs fellowship, based in Cambridge, MA. About Intellia Intellia Therapeutics is a biotechnology company focused on developing CRISPR-based gene editing therapies to transform lives of people with severe
-
to strengths-based research that advances health equity for youth of color and their families using community engaged practices. The CHANGE lab, which is housed in the IHESJR, has areas of focus ranging across
-
, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Global Medical Affairs fellowship, based in Cambridge, MA. About Intellia Intellia
-
Global Medical Information fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Medical Affairs TTR fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
Regulatory Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines
-
, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation, empirical and structure-based target design